Published August 3, 2018 | Version v1
Journal article Open

FOCAL SEGMENTAL GLOMERULOSCLEROSIS AND MULTIPLE MYELOMA.

  • 1. Cardiology, Mayo Clinic, Rochester, USA, 802 1st ST SW, Rochester, MN, USA.
  • 2. Observer In Internal Medicine, Baylor Saint Luke\'s Medical Center, Houston, USA.
  • 3. Internal Medicine, Jinnah Sindh Medical University, Karachi, PAK.
  • 4. Internal Medicine, Harvard Medical College/Beth Israel Deaconess Medical Center, Boston, USA.
  • 5. Internal Medicine, Fatima Jinnah Medical University, High Point, USA.
  • 6. Oncology, Mayo Clinic, Rochester, MN, USA.
  • 7. Internal Medicine, Liaquat University of Medical and Health Sciences Hospital Jamshoro Sindh Pakistan., Jamshoro, PAK.

Description

Focal segmental glomerulosclerosis (FSGS) is one of the most important causes of end-stage renal disease in the United States. FSGS is more prevalent in young African American patients. It is commonly associated with various conditions such as genetic abnormalities, metabolic disorders, infections, and drug abuse. FSGS is a rare disease, and its association with hematological disorders is uncommon. In this study, we are documenting a case of the FSGS due to underlying multiple myeloma. The objective of this study is to emphasize the importance of excluding hematologic disorders in the older patients before diagnosing them with idiopathic FSGS. Early diagnosis and treatment of the underlying condition responsible for the FSGS can lead to complete remission of the FSGS, thus preventing complications such as renal failure.

Files

23.pdf

Files (549.0 kB)

Name Size Download all
md5:72cb173c0fc9e22904b235fb552a3e0f
549.0 kB Preview Download